← Back to Analyst Consensus 
FOLD Hold
AMICUS THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jan 22, 2026 | Jefferies | downgrade | Buy → Hold | $14.5 | 52% |
| Dec 29, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $14.5 | 51% |
| Dec 22, 2025 | Citigroup | downgrade | Buy → Neutral | $14.5 | 54% |
| Dec 19, 2025 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Dec 19, 2025 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $14.5 | 50% |
| Dec 17, 2025 | Citigroup | initiate | — → Buy | $17 | 54% |
| Nov 6, 2025 | JP Morgan | maintain | Overweight → Overweight | $19 | 54% |
| Nov 5, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $11 | 54% |
| Sep 18, 2025 | Needham | upgrade | Hold → Buy | $14 | 50% |
| Jul 17, 2025 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $108 | 54% |
| May 2, 2025 | UBS | maintain | Buy → Buy | $22 | 54% |
| May 2, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $9 | 54% |
| Feb 20, 2025 | Wells Fargo | maintain | Overweight → Overweight | $17 | 54% |
| Feb 20, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jan 15, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $21 | 50% |
| Jan 13, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Dec 13, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $12 | 54% |
| Nov 12, 2024 | JP Morgan | maintain | Overweight → Overweight | $17 | 54% |
| Nov 7, 2024 | Guggenheim | maintain | Buy → Buy | $15 | 52% |
| Nov 7, 2024 | UBS | maintain | Buy → Buy | $21 | 54% |
| Nov 7, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $21 | 50% |
| Nov 7, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Oct 17, 2024 | B of A Securities | maintain | Buy → Buy | $15 | 53% |
| Oct 11, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $18 | 54% |
| Sep 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $20 | 50% |
| Sep 6, 2024 | Jefferies | initiate | — → Buy | $18 | 52% |
| Aug 16, 2024 | JP Morgan | maintain | Overweight → Overweight | $16 | 54% |
| Aug 9, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| May 30, 2024 | Wells Fargo | initiate | — → Overweight | $18 | 54% |
| May 14, 2024 | Guggenheim | upgrade | Neutral → Buy | $13 | 52% |
| May 10, 2024 | UBS | maintain | Buy → Buy | $19 | 54% |
| May 10, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $19 | 54% |
| May 10, 2024 | B of A Securities | maintain | Buy → Buy | $13 | 53% |
| May 10, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Mar 18, 2024 | JP Morgan | maintain | Overweight → Overweight | $19 | 54% |
| Feb 29, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $22 | 50% |
| Dec 19, 2023 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $20 | 54% |
| Nov 9, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $15 | 54% |
| Oct 10, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $14 | 54% |
| Sep 29, 2023 | JP Morgan | maintain | Overweight → Overweight | $19 | 54% |
| Jul 11, 2023 | Morgan Stanley | reiterate | Equal-Weight → Equal-Weight | $15 | 54% |
| Mar 28, 2023 | B of A Securities | maintain | — → Buy | $17 | 53% |
| Mar 2, 2023 | UBS | maintain | — → Buy | $17 | 54% |
| Mar 2, 2023 | Goldman Sachs | maintain | — → Neutral | $11 | 54% |
| Jan 18, 2023 | BTIG | maintain | — → Buy | $16 | 52% |
| Nov 8, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $15 | 54% |
| Sep 9, 2022 | Morgan Stanley | initiate | — → Equal-Weight | $14 | 54% |
| Feb 24, 2022 | SVB Leerink | maintain | — → Outperform | $14 | — |
| Jan 14, 2022 | SVB Leerink | upgrade | Market Perform → Outperform | $16 | — |
| Jan 13, 2022 | Cantor Fitzgerald | maintain | — → Overweight | $15 | 50% |
Price Target Trend
Apr 23, 2026 Latest: $14.5 Jun 26, 2026
EPS Estimates
0y $0.07
Lo: $0.07 Hi: $0.07
1 analysts +1y $0.82
Lo: $0.47 Hi: $0.97
4 analysts +1q $0.02
Lo: $0.02 Hi: $0.02
1 analysts 0q $-0.08
Lo: $-0.08 Hi: $-0.08
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days